Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis
Journal of Gastroenterology and Hepatology · 2024
DOI: 10.1111/jgh.16552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Kazuma Mori und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Fatty Liver. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background and Aim New nomenclature of steatotic liver disease (SLD) including metabolic dysfunction‐associated SLD (MASLD), MASLD and increased alcohol intake (MetALD), and alcohol‐associated liver disease (ALD) has recently been proposed. We investigated clustering analyses to decipher the complex landscape of SLD pathologies including the former nomenclature of nonalcoholic fatty liver disease (NAFLD) and metabolic dysfunction‐associated fatty liver disease (MAFLD).
Methods
Japanese individuals who received annual health checkups including abdominal ultrasonography ( n = 15 788, men/women: 10 250/5538, mean age: 49 years) were recruited.
Results
The numbers of individuals with SLD, MASLD, MetALD, ALD, NAFLD, and MAFLD were 5603 (35.5%), 4227 (26.8%), 795 (5.0%), 324 (2.1%), 3982 (25.8%), and 4946 (31.3%), respectively. Clustering analyses using t‐distributed stochastic neighbor embedding and K‐means to visually represent interconnections in SLDs uncovered five cluster formations. MASLD and NAFLD mainly shared three clusters including (i) low alcohol intake with relatively low‐grade obesity; (ii) obesity with dyslipidemia; and (iii) dysfunction of glucose metabolism. Both MetALD and ALD displayed one distinct cluster intertwined with alcohol consumption. MAFLD widely shared all of the five clusters. In machine learning‐based analyses using algorithms of random forest and extreme gradient boosting and receiver operating characteristic curve analyses, fatty liver index (FLI), calculated by body mass index, waist circumference, and levels of γ‐glutamyl transferase and triglycerides, was selected as a useful feature for SLDs.
Conclusions
The new nomenclature of SLDs is useful for obtaining a better understanding of liver pathologies and for providing valuable insights into predictive factors and the dynamic interplay of diseases. FLI may be a noninvasive predictive marker for detection of SLDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Department of Immunology and Microbiology, National Defense Medical College, Tokorozawa, Japan.
- Department of Neurosurgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Department of Cellular Physiology and Signal Transduction, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Department of Cardiovascular Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Department of Health Checkup and Promotion, Keijinkai Maruyama Clinic, Sapporo, Japan.
ORCID-Profile: Masato Furuhashi
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Mori, K., Akiyama, Y., Tanaka, M., Sato, T., Endo, K., Hosaka, I., Hanawa, N., Sakamoto, N., & Furuhashi, M. (2024). Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16552
Vancouver
Mori K, Akiyama Y, Tanaka M, Sato T, Endo K, Hosaka I, et al. Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16552
BibTeX
@article{Mori2024,
author = {Mori, Kazuma and Akiyama, Yukinori and Tanaka, Marenao and Sato, Tatsuya and Endo, Keisuke and Hosaka, Itaru and Hanawa, Nagisa and Sakamoto, Naoya and Furuhashi, Masato},
title = {Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
doi = {10.1111/jgh.16552}
}
EUVIMED